Sector:
Healthcare
Location:
Bedford, MA
Year Funded:
1997
Status:
IPO
|
|
 Summary:
NitroMed was the maker of BiDil (isosorbide dinitrate/hydralazine hydrochloride), an orally administered medicine available in the United States for the treatment of heart failure in self-identified black patients.
|
|